38
Participants
Start Date
May 15, 2007
Primary Completion Date
March 5, 2008
Study Completion Date
March 5, 2008
inhaled human insulin
Treat-to-target dose titration scheme, pre-prandial, inhalation.
insulin aspart
Treat-to-target dose titration scheme, pre-prandial, injection s.c.
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Changhua
Novo Nordisk Investigational Site, Chiayi City
Novo Nordisk Investigational Site, Ciudad de Buenos Aires
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Erzurum
Novo Nordisk Investigational Site, Gaziantep
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Kocaeli
Novo Nordisk Investigational Site, Chandigarh
Novo Nordisk Investigational Site, Pune
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Vellore
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Buenos Aires
Novo Nordisk Investigational Site, Buenos Aires
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Bucharest
Novo Nordisk Investigational Site, Bucharest
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Ľubochňa
Novo Nordisk Investigational Site, Moldava nad Bodvou
Novo Nordisk Investigational Site, Žilina
Novo Nordisk Investigational Site, Žilina
Lead Sponsor
Novo Nordisk A/S
INDUSTRY